2-Biphenylboronic acid | CAS:4688-76-0

We serve 2-Biphenylboronic acid CAS:4688-76-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Biphenylboronic acid

Product Name: 2-Biphenylboronic acid
Other Name:
2-Biphenylboronic acid
(2-phenylphenyl)boronic acid
Biphenyl-2-boronic acid
CAS No: 4688-76-0
MF: C12H11BO2
MW: 198.02600
Density: 1.18 g/cm3
Boiling point: 404ºC at 760 mmHg
Melting point: 167-172 °C(lit.)
Flash point: 198.1ºC
UN Number: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2-Biphenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Biphenyl-2-boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2-phenylphenyl)boronic acid Use and application,2-Biphenylboronic acid technical grade,usp/ep/jp grade.


Related News: Massachusetts state health officials, in conjunction with Massport, local health departments, and other medical partners, have responded to prevent the spread of the virus.1,4-Dibromobutane manufacturer Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.6-(chloromethyl)-11H-benzo[c][1]benzazepine supplier Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.4-Bromo-2-Cyanopyridine vendor Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.